Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,597,000 | 5,873,000 | 2,223,000 | 3,057,000 | 2,270,544 |
| Depreciation Amortization | 775,000 | 507,000 | 241,000 | 345,000 | 216,745 |
| Income taxes - deferred | -67,000 | -53,000 | -3,000 | -98,000 | -12,400 |
| Accounts receivable | -827,000 | -1,332,000 | -1,118,000 | -315,000 | -226,308 |
| Accounts payable and accrued liabilities | -75,000 | -90,000 | -20,000 | -98,000 | 23,131 |
| Other Working Capital | 174,000 | -770,000 | -982,000 | -562,000 | -370,727 |
| Other Operating Activity | 1,220,000 | 1,618,000 | 1,227,000 | 776,000 | 477,216 |
| Operating Cash Flow | $9,797,000 | $5,753,000 | $1,568,000 | $3,105,000 | $2,378,201 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,028,000 | -393,000 | 3,000 | 315,000 | 29,190 |
| PPE Investments | -390,000 | -255,000 | -164,000 | -190,000 | -121,310 |
| Net Acquisitions | N/A | N/A | N/A | -379,000 | -378,645 |
| Investing Cash Flow | $-1,418,000 | $-648,000 | $-161,000 | $-254,000 | $-470,765 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,594,000 | 5,278,000 | 4,569,000 | 2,774,000 | 1,257,869 |
| Debt Repayment | -2,886,000 | -2,465,000 | -1,445,000 | -4,440,000 | -2,224,782 |
| Common Stock Issued | 275,000 | 163,000 | 109,000 | 313,000 | 240,671 |
| Common Stock Repurchased | -3,348,000 | -1,650,000 | -450,000 | -582,000 | -182,259 |
| Other Financing Activity | -3,894,000 | 187,000 | 101,000 | -609,000 | -790,381 |
| Financing Cash Flow | $-4,259,000 | $1,513,000 | $2,884,000 | $-2,544,000 | $-1,698,882 |
| Exchange Rate Effect | -24,000 | N/A | N/A | 2,000 | -1,512 |
| Beginning Cash Position | 2,113,000 | 2,113,000 | 2,113,000 | 1,804,000 | 1,803,694 |
| End Cash Position | 6,209,000 | 8,731,000 | 6,404,000 | 2,113,000 | 2,010,736 |
| Net Cash Flow | $4,096,000 | $6,618,000 | $4,291,000 | $309,000 | $207,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,797,000 | 5,753,000 | 1,568,000 | 3,105,000 | 2,378,201 |
| Capital Expenditure | -390,000 | -255,000 | -164,000 | -190,000 | -121,310 |
| Free Cash Flow | 9,407,000 | 5,498,000 | 1,404,000 | 2,915,000 | 2,256,891 |